# A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

> **NCT03168334** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 801 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** IDP-123 Lotion
- **DRUG:** IDP-123 Vehicle Lotion

## Key facts

- **NCT ID:** NCT03168334
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-11
- **Primary completion:** 2018-07-24
- **Final completion:** 2018-07-24
- **Target enrollment:** 801 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168334, "A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03168334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*